Open AccessIschemia Modified Albumin (IMA) - A Marker of Glycaemic Control and Vascular Complications in Type 2 Diabetes Mellitus
Author(s) -
Rajinder Chawla,
Rinchu Loomba,
Deepak Guru,
Vikas Loomba
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/15282.7432
Subject(s) - medicine , ischemia modified albumin , diabetes mellitus , type 2 diabetes mellitus , creatinine , albumin , etiology , ischemia , statistical significance , lipid profile , surgery , gastroenterology , endocrinology , myocardial ischemia
Ischemia modified albumin (IMA) has emerged as a marker for ischemic injury and oxidative damage, particularly in myocardial infarction. There are very few studies on the significance of IMA in other conditions associated with ischemia. The complications of diabetes mellitus (DM) arising out of poor glycaemic control have an underlying ischemic aetiology.